Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
Active, not recruiting · NCT06738017 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Active, not recruiting | Phase 1 | 2026-05-06 | NCT06738017 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioMarin Pharmaceutical | 32 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medpace Clinical Pharmacology Unit | Cincinnati | United States | 3 |
| NHS Lothian | Edinburgh | United Kingdom | 1 |
| Royal Free London NHS Foundation Trust | London | United Kingdom | 1 |
| Saint Louis University | St Louis | United States | 18 |
| The Medical University of South Carolina | Charleston | United States | 5 |
| University Hospital Southampton NHS Foundation Trust | Southampton | United Kingdom | 1 |
| University of California, San Diego | San Diego | United States | 13 |